Scarica l'app Stockscreener
4.49
5.07%
-0.24
Dopo l'orario di chiusura:
4.70
0.21
+4.68%
Precedente Chiudi:
$4.73
Aprire:
$4.8
Volume 24 ore:
42,468
Relative Volume:
0.10
Capitalizzazione di mercato:
$132.21M
Reddito:
-
Utile/perdita netta:
-
Rapporto P/E:
-
EPS:
-
Flusso di cassa netto:
-
1 W Prestazione:
+21.02%
1M Prestazione:
+4.18%
6M Prestazione:
+0.00%
1 anno Prestazione:
+0.00%
Intervallo 1D:
$4.48
$4.99
Intervallo di 1 settimana:
$3.678
$5.22
Portata 52W:
$2.5701
$26.50
Turn Therapeutics Inc Stock (TTRX) Company Profile
Nome
Turn Therapeutics Inc
Settore
Industria
Telefono
(818) 564-4011
Indirizzo
250 NORTH WESTLAKE BLVD., WESTLAKE VILLAGE
Confronta TTRX con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
TTRX
Turn Therapeutics Inc
|
4.49 | 139.28M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
468.38 | 113.87B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
776.54 | 80.22B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
406.40 | 52.56B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
803.74 | 49.31B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
175.07 | 37.37B | 447.02M | -1.18B | -906.14M | -6.1812 |
Turn Therapeutics Inc Stock (TTRX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-12-29 | Iniziato | D. Boral Capital | Buy |
Turn Therapeutics Inc Borsa (TTRX) Ultime notizie
Ceapro (OTCMKTS:CRPOF) vs. Turn Therapeutics (NASDAQ:TTRX) Head to Head Review - Defense World
Turn Therapeutics (NASDAQ:TTRX) Upgraded at D Boral Capital - Defense World
Turn Therapeutics (NASDAQ:TTRX) Now Covered by Analysts at D. Boral Capital - Defense World
TTRX Analyst Forecasts - Quiver Quantitative
Turn Therapeutics Inc. Common Stock (TTRX) Stock News & Articles - 24/7 Wall St.
D. Boral Capital initiates Turn Therapeutics stock with Buy rating By Investing.com - Investing.com Canada
What date does Turn Therapeutics Inc.'s (TTRX) report EarningsEarnings Calendar & Announcement - Zacks Investment Research
Death Cross: Is Beam Therapeutics Inc. stock a defensive play in 2025Exit Point & Safe Entry Zone Identification - moha.gov.vn
12 Health Care Stocks Moving In Tuesday's Pre-Market Session - Benzinga
Will Tempest Therapeutics Inc. stock beat EPS estimatesJuly 2025 Weekly Recap & Weekly High Potential Stock Alerts - bolumsonucanavari.com
Portfolio Shifts: Is Enliven Therapeutics Inc. stock near bottom after decline2025 Volatility Report & Daily Entry Point Trade Alerts - moha.gov.vn
Will Whitehawk Therapeutics Inc. stock recover faster than market2025 Earnings Surprises & Detailed Earnings Play Alerts - Улправда
Can Karyopharm Therapeutics Inc. stock resist sector downturnsJuly 2025 Market Mood & High Accuracy Trade Alerts - Улправда
Why MiNK Therapeutics Inc. stock attracts global investors2025 Market Trends & Short-Term High Return Ideas - Улправда
Is Foghorn Therapeutics Inc. stock resilient to inflation2025 Support & Resistance & Real-Time Chart Breakout Alerts - Улправда
Why Anika Therapeutics Inc. stock remains on watchlistsMarket Activity Report & Community Trade Idea Sharing - Улправда
Will Neumora Therapeutics Inc. stock benefit from AI adoptionOil Prices & Weekly Setup with High ROI Potential - Улправда
Loss Report: Can Xilio Therapeutics Inc. stock outperform in 2025 bull marketJuly 2025 EndofMonth & High Win Rate Trade Alerts - Улправда
Will Intensity Therapeutics Inc. stock split attract more investorsJuly 2025 News Drivers & AI Based Buy and Sell Signals - Улправда
How geopolitical tensions affect Spyre Therapeutics Inc. stock2025 Historical Comparison & Real-Time Volume Trigger Notifications - ulpravda.ru
Is Cidara Therapeutics Inc. stock a top momentum playMarket Activity Report & AI Enhanced Trade Execution Alerts - Улправда
Is Beam Therapeutics Inc. stock cheap compared to fundamentalsMarket Growth Report & Short-Term High Return Strategies - Улправда
Is Aquestive Therapeutics Inc. stock positioned for digital transformation2025 Key Highlights & Expert Approved Trade Ideas - Улправда
Will Tempest Therapeutics Inc. stock split again soonJuly 2025 Earnings & Accurate Intraday Trading Signals - Улправда
How Marker Therapeutics Inc. (GX1) stock reacts to new regulationsJuly 2025 Earnings & Low Volatility Stock Recommendations - Улправда
Will TG Therapeutics Inc. stock benefit from automationMarket Activity Report & Free Expert Verified Stock Movement Alerts - Улправда
Turn Therapeutics Inc. (TTRX) - Zacks Investment Research
CFO Chaudhary Buys 2,500 ($8.8K) Of Turn Therapeutics Inc [TTRX] - TradingView — Track All Markets
Can Black Diamond Therapeutics (BDTX) Turn Silevertinib’s Dual-Cancer Ambition Into a Cohesive Strategy? - Yahoo Finance
Is CytomX Therapeutics Inc. (6C1) stock attractive for dividend growthJuly 2025 Snapshot & Technical Pattern Based Buy Signals - moha.gov.vn
Why Intensity Therapeutics Inc. stock appeals to analystsQuarterly Portfolio Review & Free Risk Controlled Daily Trade Plans - moha.gov.vn
Volatility Watch: Why Seres Therapeutics Inc. stock is rated strong buyJuly 2025 Review & High Accuracy Trade Alerts - moha.gov.vn
Arthur Golden Increases Stake in Turn Therapeutics Inc with Rece - GuruFocus
Golden Arthur F buys Turn Therapeutics shares worth $33945 By Investing.com - Investing.com Nigeria
Golden Arthur F buys Turn Therapeutics shares worth $33945 - Investing.com
Turn Therapeutics Director Arthur F Golden Acquires 9,868 Shares - TradingView
Dir Golden Buys 9,868 ($33.9K) Of Turn Therapeutics Inc [TTRX] - TradingView
Insider Buying: Arthur Golden Acquires Additional Shares of Turn Therapeutics Inc (TTRX) - GuruFocus
Turn Therapeutics Director Arthur F. Golden Acquires 20,532 Shares - TradingView
Dir Golden Buys 20,532 ($58.9K) Of Turn Therapeutics Inc [TTRX] - TradingView
[Form 4] Turn Therapeutics Inc. Insider Trading Activity - Stock Titan
Turn Therapeutics Inc. Common Stock trading resumes - MSN
Zuraiz Chaudhary buys Turn Therapeutics (TTRX) shares worth $9,050 By Investing.com - Investing.com Nigeria
Zuraiz Chaudhary buys Turn Therapeutics (TTRX) shares worth $9,050 - Investing.com
Turn Therapeutics (TTRX) FDA Approvals, PDUFA Dates & Drug Alerts 2025 - MarketBeat
Turn Therapeutics’ GX-03 Recognized for Dermatology Innovation - MSN
Turn Therapeutics Reports Third Quarter 2025 Financial Results and Provides Corporate Updates - The Manila Times
Turn Therapeutics GX-03 Technology Named as One of Five Novel Mechanisms Reshaping Atopic Dermatitis Treatment by Patient Care Online Magazine - MarketScreener
Turn Therapeutics (Nasdaq: TTRX) features Dr. Robert Redfield on trust in science - Stock Titan
Turn Therapeutics’ GX-03 Technology Named as One of 'Five Novel Mechanisms Reshaping Atopic Dermatitis Treatment” by Patient Care Online Magazine - The Manila Times
Turn (NASDAQ: TTRX) named among five novel eczema mechanisms by Patient Care Online - Stock Titan
Turn Therapeutics Inc Azioni (TTRX) Dati Finanziari
Non sono disponibili dati finanziari per Turn Therapeutics Inc (TTRX). Controlla altri titoli per ulteriori informazioni.
Reddito
Reddito netto
Flusso di cassa
EPS
2.52%
0.07%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):